SBShiloh Bolden

Shiloh Bolden

*This is an algorithmically generated author record based on publicly available information.

Shiloh Bolden has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Degradation of Nitrogen-containing Pharmaceuticals by Anammox Bacteria: Inhibition and Nitrogen Removal

    by Shiloh Bolden, Lilith Astete Vasquez, David A. Lipson, Polina Popova, Natalie Mladenov

    Anaerobic ammonium-oxidizing (anammox) bacteria effectively remove nitrogen from wastewater and are widely used in sidestream processes, such as the treatment of centrate, which contains high concentrations of pharmaceuticals. To evaluate the role that anammox bacteria play in degrading nitrogen-containing pharmaceuticals, we exposed biomass from an anammox enrichment reactor to a synthetic wastewater mixture containing caffeine, carbamazepine, sulfamethoxazole, trimethoprim, and fluoxetine (Pharm condition). These compounds were introduced at elevated concentrations, typically observed in agricultural wastewater or in municipal sludge and sidestream processes. Despite significant reduction in the ammonium removal efficiency in the Pharm condition (~20% lower than No-Pharm conditions), total dissolved nitrogen removal efficiencies were still high (76% ± 2.7% under Pharm compared to 91.7% under No-Pharm). 16S rRNA gene sequencing showed that pharmaceutical exposure changed the microbial community, causing a reduction in the relative abundance of anammox species, including Candidatus Brocadia sinica and C. Brocadia fulgida, but an increase in other microbial communities. Nitrite was completely removed under the Pharm condition, possibly due to increased abundance of the denitrifier Hyphomicrobium vulgare in this condition. Incubations containing anammox reactor biomass showed higher pharmaceutical removals than abiotic controls and autoclaved samples, but the removals were only significant for caffeine and trimethoprim. Heterotrophs Zeimonas arvi and Aggregatilinea lenta increased in abundance and may have contributed to pharmaceutical removal through co-metabolism. This research leads to a better understanding of both the resilience of anaerobic consortia containing anammox and the effect that mixtures of pharmaceuticals have on systems that rely on biological removal of nitrogen.

  • Open Access

    Degradation of Nitrogen-containing Pharmaceuticals by Anammox Bacteria: Inhibition and Nitrogen Removal

    by Shiloh Bolden, Lilith Astete Vasquez, David A. Lipson, Polina Popova, Natalie Mladenov

    Anaerobic ammonium-oxidizing (anammox) bacteria effectively remove nitrogen from wastewater and are widely used in sidestream processes, such as the treatment of centrate, which contains high concentrations of pharmaceuticals. To evaluate the role that anammox bacteria play in degrading nitrogen-containing pharmaceuticals, we exposed biomass from an anammox enrichment reactor to a synthetic wastewater mixture containing caffeine, carbamazepine, sulfamethoxazole, trimethoprim, and fluoxetine. These compounds were introduced at elevated concentrations, typically observed in agricultural wastewater or in municipal sludge and sidestream processes. After 84 hours, ammonium removal efficiency was significantly reduced (by 20%) in incubations with elevated pharmaceutical concentrations compared to controls with no pharmaceuticals, but ~70% ± 3.0% of total dissolved nitrogen was still removed. 16S rRNA gene sequencing showed that pharmaceutical exposure changed the microbial community, causing a reduction in the relative abundance of anammox species, including Candidatus Brocadia sinica and C. Brocadia fulgida. Despite reduced anammox species abundance, nitrite was completely removed, possibly due to increased abundance of the denitrifier Hyphomicrobium vulgare, which was more abundant in the pharmaceutical condition. Incubations containing anammox reactor biomass showed higher pharmaceutical removals than abiotic controls and autoclaved samples, but the removals were only significant for xxx. Heterotrophs Zeimonas arvi and Aggregatilinea lenta increased in abundance and may have contributed to pharmaceutical removal through co-metabolism. This research therefore leads to a better understanding of both the resilience of anaerobic consortia containing anammox and effect that mixtures of pharmaceuticals have on systems that rely on biological removal of nitrogen.